Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 24.9K | $473K | $19.00 | Feb 13, 2024 | Indirect |
NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 9.88K | $188K | $19.00 | Dec 29, 2023 | Direct |
NewAmsterdam Pharma Co N.V. | Director | Option (right to buy) | 10K | Jan 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Feb 13, 2024 | 1 | $95K | 4 | Feb 21, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3/A | Jan 25, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Director |
EPHY | Epiphany Technology Acquisition Corp. | Sep 16, 2022 | 0 | $0 | 3 | Oct 4, 2022 | Director |
BIOS | BioPlus Acquisition Corp. | Dec 2, 2021 | 0 | $0 | 3 | Dec 2, 2021 | Director |